Catalyst
Slingshot members are tracking this event:
Arrowhead Pharma (ARWR) Presents Data on ARC-520 in Treatment of Hepatitis B at The International Liver Congress 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARWR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 13, 2016
Occurred Source:
http://www.businesswire.com/news/home/20160413005533/en/Arrowhead-Pharmaceuticals-Presents-Promising-ARC-520-Hepatitis-Data
Related Projects
- Discussing the Potential of Arrowhead Pharma's (ARWR) ARC-520 in Treatment of Hepatitis-B After Positive Phase 1 Results ARWR, BMY Executed On: Apr 26, 2016 at 02:00 PM EDT
Related Keywords
Arc-520, Hepatitis B, The International Liver Congress 2016
